Rakesh Jhunjhunwala trims stake in Fortis Healthcare even as stock rallies over 72% so far this year

By: |
October 18, 2021 12:03 PM

Rakesh Jhunjhunwala has cut a stake in a healthcare firm Fortis Healthcare to 4.23 per cent

Rakesh Jhunjhunwala, Fortis HealthcareAccording to the latest shareholding pattern, the Rakesh Jhunjhunwala has trimmed his stake by 6 lakh shares.

Rakesh Jhunjhunwala has cut a stake in a healthcare firm Fortis Healthcare to 4.23 per cent. Jhunjhunwala held a 4.31 per cent stake or 3.25 crore shares of the firm, as of 30 June 2021. According to the latest shareholding pattern, the ace investor has trimmed his stake by 6 lakh shares. Fortis Healthcare shares have been underperforming the equity benchmarks. In the last five days, the stock fell 1.12 per cent, even as BSE Sensex and Nifty 50 soared to fresh highs.

However, Fortis Healthcare stock has gained 3.25 per cent in the last one month, and a massive 34 per cent in six months. On a year-to-date (YTD) basis, the stock has rallied 72.15 per cent to Rs 268.5 apiece from Rs 156 apiece. Last week, big bull reduced his stake to below one per cent in pharma major Lupin.

Also read: Rakesh Jhunjhunwala made Rs 1,331 crore from 2 Tata Group stocks this week; shares jump as much as 30%

Analysts say that with a high net worth investor reducing his stake in the company and more demand for risky sector bets at all-time highs, Fortis Healthcare is seeing a correction. “Technically, 277 level is a massive resistance and only a daily close above this level would trigger an uptrend. 255-260 remains crucial support,” AR Ramachandran, Co-founder & Trainer, Tips2Trades, told Financial Express Online.

Fortis Healthcare stock was trading in red at Rs 268 apiece on BSE, in late morning deals, even as BSE Sensex soared 0.74 per cent, ruling at fresh high. In traded volume terms, 40,000 shares have traded so far on BSE, while a total of 13.30 lakh shares have exchanged hands on NSE. Fortis Healthcare share price has declined over 21 per cent from its peak of Rs 304, touched on 30 August 2021. “Although the non-Covid business of the Fortis Healthcare has increased, it may take 12-15 months to come back to normal or pre-Covid level,” Akhilesh Jat, Pharma Analyst at CapitalVia Global Research, told Financial Express Online

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Godrej Properties Rating: Buy- Leadership position is well deserved
2Reliance Industries Rating: Buy- Tariff hike to boost Jio’s ARPUs, valuation
3Banks, companies rush to bond market to lock lower rates